6547.TWO
Price:
$62
Market Cap:
$20.38B
Medigen Vaccine Biologics Corporation, a biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan. It develops enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection with severe complications; and Quadrivalent influenza vaccine, which is in Phase III clinical trial for the treatment of influenza viruses. The company also develops dengue vaccines, which has completed Phase II clinical trial to treat dengue; anti respiratory syncytial virus (RSV), which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinica...[Read more]
Industry
Biotechnology
IPO Date
2015-09-16
Stock Exchange
TWO
Ticker
6547.TWO
According to Medigen Vaccine Biologics Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 22.37. This represents a change of 38.55% compared to the average of 16.15 of the last 4 quarters.
The mean historical Current Ratio of Medigen Vaccine Biologics Corp. over the last ten years is 8.62. The current 22.37 Current Ratio has changed 25.85% with respect to the historical average. Over the past ten years (40 quarters), 6547.TWO's Current Ratio was at its highest in in the March 2023 quarter at 26.39. The Current Ratio was at its lowest in in the September 2016 quarter at 0.
Average
8.62
Median
8.82
Minimum
2.21
Maximum
15.38
Discovering the peaks and valleys of Medigen Vaccine Biologics Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 448.11%
Maximum Annual Current Ratio = 15.38
Minimum Annual Increase = -85.63%
Minimum Annual Current Ratio = 2.21
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 12.77 | 6.97% |
| 2024 | 11.94 | 440.14% |
| 2023 | 2.21 | -85.63% |
| 2022 | 15.38 | 81.44% |
| 2021 | 8.47 | -32.12% |
| 2020 | 12.48 | 448.11% |
| 2019 | 2.28 | -59.44% |
| 2018 | 5.62 | -4.66% |
| 2017 | 5.89 | -35.72% |
| 2016 | 9.16 | -1.01% |
The current Current Ratio of Medigen Vaccine Biologics Corp. (6547.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.97
5-year avg
10.15
10-year avg
8.62
Medigen Vaccine Biologics Corp.’s Current Ratio is less than Advagene Biopharma Co., Ltd. (44.32), greater than Adimmune Corporation (4.47), greater than TaiMed Biologics Inc. (15.48), greater than Enimmune corporation (1.01),
| Company | Current Ratio | Market cap |
|---|---|---|
| 44.32 | $1.64B | |
| 4.47 | $8.09B | |
| 15.48 | $16.57B | |
| 1.01 | $1.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Vaccine Biologics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medigen Vaccine Biologics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Medigen Vaccine Biologics Corp.'s Current Ratio?
How is the Current Ratio calculated for Medigen Vaccine Biologics Corp. (6547.TWO)?
What is the highest Current Ratio for Medigen Vaccine Biologics Corp. (6547.TWO)?
What is the 3-year average Current Ratio for Medigen Vaccine Biologics Corp. (6547.TWO)?
What is the 5-year average Current Ratio for Medigen Vaccine Biologics Corp. (6547.TWO)?
How does the current Current Ratio for Medigen Vaccine Biologics Corp. (6547.TWO) compare to its historical average?